| Mar 18 2019 |
Data Call-in for Reproductive Toxicity Data on Cannabis Under California’s Proposition 65 |
Keller and Heckman LLP |
| Mar 15 2019 |
Bomb Squad Officer with Hand Tremors Can Be Temporarily Transferred Pending a Medical Exam |
Barnes & Thornburg LLP |
| Mar 15 2019 |
New York (Again) Seeks to Regulate Pharmacy Benefit Managers |
Mintz |
| Mar 15 2019 |
The Regulation of Employers’ Workplace Violence Prevention Programs Under OSHA’s General Duty Clause |
Proskauer Rose LLP |
| Mar 15 2019 |
HHS and USDA Announce 2020 Dietary Guidelines Topics and Advisory Committee Meeting |
Keller and Heckman LLP |
| Mar 15 2019 |
McDermottPlus Check-Up: March 15, 2019 |
McDermott Will & Schulte LLP |
| Mar 15 2019 |
New OARRS Reporting Obligations Become Effective March 19, 2019 |
Dinsmore & Shohl LLP |
| Mar 14 2019 |
Cybersecurity, Inside Jobs, Outside Jobs, and HIPAA |
Sheppard, Mullin, Richter & Hampton LLP |
| Mar 14 2019 |
Caring for Our Caregivers: House Subcommittee Holds Hearing on Healthcare Workplace Violence Bill |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Mar 14 2019 |
Medicare Remote Patient Monitoring: CMS Allows “Incident to” Billing |
Foley & Lardner LLP |
| Mar 14 2019 |
Transformational Artificial Intelligence: Prioritizing AI in Healthcare While Maintaining Legal Compliance |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Mar 14 2019 |
FDA Announces New Policies on e-Cigarettes and Cigars to Stem Surge in Youth Smoking |
Keller and Heckman LLP |
| Mar 14 2019 |
Medicare Liens Attached to a Workers’ Compensation Claim |
Stark & Stark |
| Mar 13 2019 |
Judge Dismisses FCA Claims Against Compounding Pharmacy and Private Equity Firm Owner but Allows the Government to Amend |
Mintz |
| Mar 13 2019 |
Health Care Issues: 2020 Election |
Giordano, Halleran & Ciesla, P.C. |
| Mar 13 2019 |
Analyzing the President’s FY 2020 Budget: Key HHS Proposals |
McDermott Will & Schulte LLP |
| Mar 12 2019 |
Second Circuit Holds That Issuer’s Alleged Statements Concerning Its Regulatory Compliance Efforts Do Not Constitute Material Misstatements |
Sheppard, Mullin, Richter & Hampton LLP |
| Mar 12 2019 |
ERISA Administrative Appeal Barred As Untimely |
Proskauer Rose LLP |
| Mar 11 2019 |
The New Appendix Q – CMS State Operations Manual Changes Overhaul Immediate Jeopardy For Providers And Suppliers |
McDermott Will & Schulte LLP |
| Mar 11 2019 |
Eighth Circuit Rejects FCA Claim for Failure to Allege Actual Claims for Payment |
McDermott Will & Schulte LLP |
| Mar 11 2019 |
HHS Proposes Changes to the Discount Safe Harbor Framework to Realign Incentives and Put Downward Pressure on Drug Prices |
Squire Patton Boggs (US) LLP |
| Mar 11 2019 |
340B In The Spotlight – Key Program Developments |
Polsinelli PC |
| Mar 11 2019 |
U.S. Senate Holds Hearing to Examine Nationwide Nursing Home Abuse |
Stark & Stark |
| Mar 8 2019 |
OIG Advisory Opinion No. 19-03: The OIG Puts the Healthcare Benefits of Free In-Home Care and the Risks of Patient Steering in the Balance |
Sheppard, Mullin, Richter & Hampton LLP |
| Mar 8 2019 |
McDermottPLUS Check-Up: March 8, 2019 |
McDermott Will & Schulte LLP |
| Mar 8 2019 |
Reassessment of Styrene by EFSA on the Horizon |
Keller and Heckman LLP |
| Mar 8 2019 |
USDA and FDA Provide Additional Details on Joint Regulation of Cell-Cultured Meat |
Keller and Heckman LLP |
| Mar 8 2019 |
Sixth Circuit Halts Qualified Immunity Claims for Bodily Integrity of Flint Residents |
Beveridge & Diamond PC |
| Mar 8 2019 |
Clarity on the Horizon for CBD Food Products? FDA Commissioner Indicates a Path Forward |
Pierce Atwood LLP |
| Mar 8 2019 |
Ratings Agency Starting to Factor in Cyber Risk Profile |
K&L Gates LLP |
| Mar 7 2019 |
Device Modernization Series: In Vitro Clinical Tests |
Mintz |
| Mar 7 2019 |
FDA Warns of Asbestos Contamination in Certain Cosmetics |
Keller and Heckman LLP |
| Mar 6 2019 |
Latest HIPAA Breach Involves Medical Records Hack of Business Associate |
Mintz |
| Mar 6 2019 |
What to Expect at FDA Following Commissioner Gottlieb's Departure |
Mintz |
| Mar 6 2019 |
Five Unanswered Questions on the Medicare for All Act |
McDermott Will & Schulte LLP |
